Effect of Combination Therapy of Acebutolol with Hydrochlrothiazide(Sectrazide(R)) on the Serum Lipids of Patients with Essential Hypertension.
10.4070/kcj.1984.14.2.377
- Author:
Won Sang YOO
- Publication Type:Original Article
- MeSH:
Acebutolol*;
Blood Pressure;
Cholesterol;
Compliance;
Coronary Disease;
Dyspepsia;
Humans;
Hydrochlorothiazide;
Hypertension*;
Primary Prevention;
Triglycerides
- From:Korean Circulation Journal
1984;14(2):377-383
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Serial changes of serum lipids were observed in 28 patients with essential hypertension, administered combination regimen of acebutolo 400mg and hydrochlorothiazide 25mf for up to 24 weeks. The results were as follows. 1) Serum total cholesterol and triglyceride level were varied within -6-5 and -2-7% change respectively which were not significant clinically. 2) High density lipoprotein-cholesterol decreased 5% at 6 weeks, 16% and 17% decrease in 12 and 24 weeks respecitively. The changes were more remarkable in the hyperlipidemic patients. 3) Pretreatment average blood pressure of 174/104mmHg lowered to 144/88 at 6 weeks and normalized to 135/86 at 12 weeks. 4) No adverse reaction were observed except mild weakness and indigestion which did not force the discontinuation of drugs. In summary, the fixed-ratio combination of acebutolol and hydrochlorothiazide was excellent in antihypertensive efficacy and patient's compliance, although decrease in high density lipoprotein-cholesterol demand the physician alert to exert vigilance especially in young hypertensives and hyperlipidemic patient to check serum lipids before and during medication, and to change regimen if metabolic derangement is detected in the view point of primary prevention of coronary heart disease.
